FDA Inspection
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. – FDA Inspection, Aug 3, 2018
Record Details
This FDA Inspection record concerns Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd., with an inspection on August 3, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 3, 2018
- Product Type
- Drugs
View Company Profile
ID · 22c101b0-0313-4d17-9552-3c19288bdec6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1063706
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 5, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 11, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
- FDA Inspection 1238380 - 2024-04-05
- FDA Inspection 921555 - 2015-03-20
- FDA Inspection 754956 - 2011-11-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.